News | December 31, 2024
Senores Pharmaceuticals IPO lists at 53% premium
The company's portfolio includes 21 commercialized products, 19 approved ANDAs, 4 CGT designations, 6 filed ANDAs, and 45 products in its pipeline
The company's portfolio includes 21 commercialized products, 19 approved ANDAs, 4 CGT designations, 6 filed ANDAs, and 45 products in its pipeline
Karkinos is in the business of providing technology-driven, innovative solutions for the early detection, diagnosis, and management of cancer.
The transaction is expected to result in approximately $175 million to support further development of IMG-007
Aster DM Healthcare and Quality Care India Limited have signed definitive agreements to merge, subject to regulatory, corporate and shareholders’ approvals
The product will be marketed by Dr. Reddy's
The Scheme is subject to approval of the secured creditors and shareholders of TML and GTBL
The offer price is approximately 4.32% below the closing price of the Merck common stock on November 11, 2024
Emcure has launched an awareness campaign to help spread the word about male anemia
Revenue at Rs 3,623 crore, EBITDA at Rs 718 crore
The proceeds from its fresh issuance to the extent of Rs 107 crore will be utilized for funding the capital expenditure requirements
Subscribe To Our Newsletter & Stay Updated
